Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,531Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3ALFRED E TIEFENBACHER GmbH & Co KG

02 3Pharmathen SA

03 3Biofarma Pharmaceutical Industry and Commerce Inc

04 3Farabi Pharmaceutical

05 3Intas Pharmaceuticals

06 3World Medicine

07 3Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Repaglinide

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Packaging :

Regulatory Info : EU Approved

Repaglinide

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Pharmathen

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Repaglinide

Dosage : Tablet

Dosage Strength : 1MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Repaglinide

Dosage : Tablet

Dosage Strength : 2MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Packaging :

Regulatory Info : EU Approved

Repaglinide

Dosage : Tablet

Dosage Strength : 1MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Pharmathen

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Packaging :

Regulatory Info : EU Approved

Repaglinide

Dosage : Tablet

Dosage Strength : 2MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Pharmathen

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : Diafree

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging : 30 Tablet / Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name : Diafree

Approval Date :

Application Number :

Registration Country : Turkey

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : Diafree

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging : 30 Tablet / Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : Tablet

Dosage Strength : 1MG

Brand Name : Diafree

Approval Date :

Application Number :

Registration Country : Turkey

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : Diafree

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging : 30 Tablet / Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : Tablet

Dosage Strength : 2MG

Brand Name : Diafree

Approval Date :

Application Number :

Registration Country : Turkey

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : Novofar

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name : Novofar

Approval Date :

Application Number :

Registration Country : Iran

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : Novofar

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : Tablet

Dosage Strength : 1MG

Brand Name : Novofar

Approval Date :

Application Number :

Registration Country : Iran

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

12

2024 ACI Convention
Not Confirmed
arrow

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

13

2024 ACI Convention
Not Confirmed
arrow

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

14

2024 ACI Convention
Not Confirmed
arrow

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : INSVADA

Dosage Form : TABLETS

Dosage Strength : 0.5MG

Packaging : 30 TABLETS

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : TABLETS

Dosage Strength : 0.5MG

Brand Name : INSVADA

Approval Date :

Application Number :

Registration Country : Turkey

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : INSVADA

Dosage Form : TABLETS

Dosage Strength : 1MG

Packaging : 30 TABLETS

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : TABLETS

Dosage Strength : 1MG

Brand Name : INSVADA

Approval Date :

Application Number :

Registration Country : Turkey

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name : INSVADA

Dosage Form : TABLETS

Dosage Strength : 2MG

Packaging : 30 TABLETS

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : TABLETS

Dosage Strength : 2MG

Brand Name : INSVADA

Approval Date :

Application Number :

Registration Country : Turkey

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : DC Granules and Tablet...

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Dosage : DC Granules and Tablet...

Dosage Strength : 0.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : DC Granules and Tablet...

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Repaglinide

Brand Name :

Dosage Form : DC Granules and Tablet...

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow